Genetic architecture of host proteins involved in SARS-CoV-2 infection

[1]  Christopher D. Brown,et al.  Widespread dose-dependent effects of RNA expression and splicing on complex diseases and traits , 2019, bioRxiv.

[2]  Dain R. Brademan,et al.  Large-Scale Multi-omic Analysis of COVID-19 Severity , 2020, Cell Systems.

[3]  Barbara B. Shih,et al.  Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.

[4]  F. Janvier,et al.  ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults. , 2020, Haematologica.

[5]  M. Antonelli,et al.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.

[6]  J. Erdmann,et al.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.

[7]  R. Alizadeh-Navaei,et al.  Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis , 2020, New Microbes and New Infections.

[8]  Christoph B. Messner,et al.  Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection , 2020, Cell Systems.

[9]  Spiros Denaxas,et al.  Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study , 2020, The Lancet.

[10]  Jian Chen,et al.  Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia , 2020, British journal of haematology.

[11]  Miriam Merad,et al.  Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages , 2020, Nature Reviews Immunology.

[12]  Amit N. Patel,et al.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.

[13]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[14]  F. Violi,et al.  Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge , 2020, Thrombosis and Haemostasis.

[15]  R. José,et al.  COVID-19 cytokine storm: the interplay between inflammation and coagulation , 2020, The Lancet Respiratory Medicine.

[16]  Q. Fan,et al.  D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 , 2020, Journal of Thrombosis and Haemostasis.

[17]  Dengju Li,et al.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.

[18]  P. Little.  Non-steroidal anti-inflammatory drugs and covid-19 , 2020, BMJ.

[19]  M. Triassi,et al.  Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak , 2020, BMJ.

[20]  Lei Liu,et al.  Relationship between the ABO Blood Group and the COVID-19 Susceptibility , 2020, medRxiv.

[21]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[22]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[23]  Bjarni V. Halldórsson,et al.  Eighty-eight variants highlight the role of T cell regulation and airway remodeling in asthma pathogenesis , 2020, Nature Communications.

[24]  J. Luban.  SARS-CoV-2 , 2020 .

[25]  Stephen A. Williams,et al.  Plasma protein patterns as comprehensive indicators of health , 2019, Nature Medicine.

[26]  Christopher D. Brown,et al.  Widespread dose-dependent effects of RNA expression and splicing on complex diseases and traits , 2019, bioRxiv.

[27]  Yan V. Sun,et al.  Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease , 2019, Nature Genetics.

[28]  V. M. V. Program.  A catalog of genetic loci associated with kidney function from analyses of a million individuals , 2019 .

[29]  Karsten B. Sieber,et al.  A catalog of genetic loci associated with kidney function from analyses of a million individuals , 2019, Nature Genetics.

[30]  Mark R. Hurle,et al.  Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases , 2019, bioRxiv.

[31]  Stephen Burgess,et al.  A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits , 2019, Nature Communications.

[32]  Jacob F. Degner,et al.  Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval , 2019, bioRxiv.

[33]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[34]  J. Perry,et al.  Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors , 2018, JAMA.

[35]  Benjamin B. Sun,et al.  New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. , 2018, Nature Genetics.

[36]  Anthony J. Payne,et al.  Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.

[37]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[38]  Xia Yang,et al.  Co-regulatory networks of human serum proteins link genetics to disease , 2018, Science.

[39]  Ayellet V. Segrè,et al.  Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation , 2018, Nature Genetics.

[40]  Stephen Burgess,et al.  Genomic atlas of the human plasma proteome , 2018, Nature.

[41]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[42]  Kathryn S. Burch,et al.  Leveraging polygenic functional enrichment to improve GWAS power , 2017, bioRxiv.

[43]  A. Morris,et al.  Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease , 2017, PLoS genetics.

[44]  Christian Gieger,et al.  Connecting genetic risk to disease end points through the human blood plasma proteome , 2016, Nature Communications.

[45]  John P. Overington,et al.  The druggable genome and support for target identification and validation in drug development , 2016, Science Translational Medicine.

[46]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[47]  William J. Astle,et al.  Allelic Landscape of Human Blood Cell Trait Variation and Links , 2016 .

[48]  Matti Pirinen,et al.  biMM: efficient estimation of genetic variances and covariances for cohorts with high-dimensional phenotype measurements , 2016, bioRxiv.

[49]  Xiaofeng Zhu,et al.  The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals , 2016, Nature Genetics.

[50]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[51]  Tom R. Gaunt,et al.  Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel , 2015, Nature Communications.

[52]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[53]  Xiangke Liao,et al.  Correction: Corrigendum: Genome-wide adaptive complexes to underground stresses in blind mole rats Spalax , 2015, Nature Communications.

[54]  Kaanan P. Shah,et al.  A gene-based association method for mapping traits using reference transcriptome data , 2015, Nature Genetics.

[55]  Mulin Jun Li,et al.  Nature Genetics Advance Online Publication a N a Ly S I S the Support of Human Genetic Evidence for Approved Drug Indications , 2022 .

[56]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[57]  Ulf Gyllensten,et al.  Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs , 2014, Nature Communications.

[58]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[59]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[60]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[61]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[62]  W. Ouwehand,et al.  Silencing of RhoA nucleotide exchange factor, ARHGEF3, reveals its unexpected role in iron uptake. , 2011, Blood.

[63]  Y. Okada,et al.  VIP36 Protein Is a Target of Ectodomain Shedding and Regulates Phagocytosis in Macrophage Raw 264.7 Cells* , 2011, The Journal of Biological Chemistry.

[64]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[65]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[66]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[67]  A. Blom,et al.  The Factor H Variant Associated with Age-related Macular Degeneration (His-384) and the Non-disease-associated Form Bind Differentially to C-reactive Protein, Fibromodulin, DNA, and Necrotic Cells* , 2007, Journal of Biological Chemistry.

[68]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[69]  E. Henderson.  Current prospects for clinical care of acute leukemia. , 1983, Haematology and blood transfusion.